Navigation Links
Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer

JAMESBURG, N.J., April 15 /PRNewswire/ -- Phytomedics Inc., an innovative clinical stage biopharmaceutical company pioneering the development novel multi-mechanism therapeutics from natural sources, today announced that Dr. Laurie Smaldone Alsup, MD., has joined the company as its President and Chief Executive Officer. She succeeds Dr. Bertold Fridlender who is announcing his retirement, but who will remain on the company's board of directors.

"Dr. Smaldone Alsup brings to Phytomedics an extensive background in drug development as well as executive leadership in various roles," said Aki von Roy, chairman of Phytomedics board of directors. "Her distinguished career and accomplishments in the pharmaceutical industry will be an invaluable asset in moving Phytomedics products forward into the market place."

Prior to joining Phytomedics, Dr. Smaldone Alsup served a distinguished 16-year career at Bristol-Myers Squibb in various executive and R&D roles. Most recently she was VP of Corporate Strategy and Issues Management involved in developing a corporate-wide business risk management capability and process. Previously, Dr. Smaldone Alsup headed Global Regulatory Sciences for the Pharmaceutical Research Institute, overseeing the regulatory approval process and pharmacovigilance for all products. She initially joined the company as a director of clinical research oncology and held clinical development positions of increasing responsibility including oversight for HIV/AIDS and infectious diseases. In these positions, Dr. Smaldone Alsup has played a role in the development of new medications to treat chronic, debilitating, and fatal diseases. She holds an M.D. degree from Yale University School of Medicine, New Haven, CT.

Dr. Smaldone Alsup has conducted clinical research throughout her career, which has been published in medical journals and presented to her peers at leading medical symposia and congresses. Dr. Smaldone Alsup serves on the board of the Hi-Tops Teen Reproductive Health Organization and McCarter Theater in Princeton, NJ. She is also a member of The Conference Board's Strategic Risk Management Council as well as a member of the Council's Executive Committee.

"The position of President and Chief Executive Officer of Phytomedics is an outstanding opportunity to lead a company with a promising future," said Smaldone Alsup. "I look forward to advancing our strong pipeline of products through the clinic and into the market to deliver innovative and efficacious products to patients."

Commenting of Dr. Fridlender's retirement, "Dr. Fridlender has done a terrific job in transitioning Phytomedics from a virtual company, to one with a broad product pipeline, multiple technologies, and a potential blockbuster product already in late stage development," said von Roy. "We now look forward to a new era in our company's development as we transition towards our commercialization strategy."

About Phytomedics, Inc.

Phytomedics Inc. ( is focused on the discovery, development, manufacture, and commercialization novel, multi-component and multi-functional drugs from natural sources. The Company has produced a pipeline of lead compounds, several of which are in clinical development, some as far as Phase IIb. Founded by Professor Ilya Raskin, Ph.D., Phytomedics Inc. conducts most of its R&D at the Biotech Center of Rutgers University.

SOURCE Phytomedics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Phytomedics Inc. to Present at Wachovia 2008 Healthcare Conference
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... Program that includes over 2,000 technical presentations offered in symposia, oral sessions, ... and applied spectroscopy, covers a wide range of applications such as, but not ...
(Date:11/26/2015)... November 26, 2015 ... Accutest Research Laboratories, a leading ... Organization (CRO), has formed a strategic ... - Temple Health for joint work ... (Photo: ) , --> ...
(Date:11/25/2015)... , November 26, 2015 ... Global Biobanking Market 2016 - 2020 report analyzes ... maintaining integrity and quality in long-term samples, minimizing ... long-term cost-effectiveness. Automation minimizes manual errors such as ... technical efficiency. Further, it plays a vital role ...
(Date:11/25/2015)... 2 nouvelles études permettent d , identifier ... souches bactériennes retrouvées dans la plaque dentaire des ... Ces recherches  ouvrent une nouvelle voie ... l,un des problèmes de santé les plus fréquemm ... --> 2 nouvelles études permettent d , ...
Breaking Biology Technology:
(Date:11/18/2015)... Nov. 18, 2015  As new scientific discoveries deepen ... and other healthcare providers face challenges in better using ... patients. In addition, as more children continue to survive ... adulthood and old age. John M. Maris, ... Hospital of Philadelphia (CHOP) . --> ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... November 2015.   --> Paris from ... --> DERMALOG, the biometrics innovation leader, has invented the ... and fingerprints on the same scanning surface. Until now two ... fingerprints. Now one scanner can capture both on the same ...
(Date:11/17/2015)... 17, 2015  Vigilant Solutions announces today that Mr. ... of Directors. --> --> ... from the partnership at TPG Capital, one of the ... $140 Billion in revenue.  He founded and led TPG,s ... TPG companies, from 1997 to 2013.  In his first ...
Breaking Biology News(10 mins):